{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:03:17Z","timestamp":1788562997598,"version":"build-2803163510"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.1093\/humupd\/dmm012","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T08:10:43Z","timestamp":1181981443000},"page":"453-463","source":"Crossref","is-referenced-by-count":98,"title":["Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis"],"prefix":"10.1093","volume":"13","author":[{"given":"Claudia M.","family":"Greiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard M.","family":"Greiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"D\u00f6ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,6,15]]},"reference":[{"key":"key\n\t\t\t\t20171012175514_DMM012C1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/1097-0142(197902)43:2<723::AID-CNCR2820430248>3.0.CO;2-1","article-title":"Ovarian cancer. Incidence and case-control study","volume":"43","author":"Annegers","year":"1979","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.20389","article-title":"Hormone replacement therapy and incidence of hormone\u2013dependent cancers in the Norwegian women and cancer study","volume":"112","author":"Bakken","year":"2004","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1047-2797(99)00045-9","article-title":"The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935\u20131991","volume":"10","author":"Beard","year":"2000","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C5","first-page":"191","article-title":"Use of HRT and the subsequent risk of cancer","volume":"4","author":"Beral","year":"1999","journal-title":"J Epidemiol Biostatistics"},{"key":"key\n\t\t\t\t20171012175514_DMM012C6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00001648-199305000-00005","article-title":"Meta-analysis of epidemiologic dose-response data","volume":"4","author":"Berlin","year":"1993","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20171012175514_DMM012C7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/bjc.1989.320","article-title":"Risk factors for ovarian cancer: a case\u2013control study","volume":"60","author":"Booth","year":"1989","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C8","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1001\/jama.285.24.3089","article-title":"Relationship between postmenopausal hormone replacement and ovarian cancer","volume":"285","author":"Bosetti","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/oxfordjournals.aje.a009142","article-title":"Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study","volume":"145","author":"Brett","year":"1997","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1011128408146","article-title":"Reproductive and hormonal factors and ovarian cancer","volume":"12","author":"Chiaffarino","year":"2001","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2005.09.050","article-title":"The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms","volume":"118","author":"Col","year":"2005","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171012175514_DMM012C12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0895-4356(99)00179-1","article-title":"A meta-analysis of estrogen replacement and risk of epithelial ovarian cancer","volume":"53","author":"Coughlin","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C13","first-page":"711","article-title":"Determinants of ovarian cancer risk. I. Reproductive experiences and family history","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6603527","article-title":"A prospective study of postmenopausal hormone use and ovarian cancer risk","volume":"96","author":"Danforth","year":"2007","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.gme.0000188735.61994.5b","article-title":"When is it appropriate to prescribe postmenopausal hormone therapy?","volume":"13","author":"Ettinger","year":"2006","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20171012175514_DMM012C16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004143.pub2","article-title":"The Cochrane HT Study Group. Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"3","author":"Farquhar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20171012175514_DMM012C17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ijc.11083","article-title":"Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies","volume":"105","author":"Fernandez","year":"2003","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.ede.0000091606.31903.8e","article-title":"Estrogen replacement therapy and ovarian cancer","volume":"15","author":"Folsom","year":"2004","journal-title":"Epidemiology"},{"key":"key\n\t\t\t\t20171012175514_DMM012C19","first-page":"472","article-title":"Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis","volume":"92","author":"Garg","year":"1998","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/archinte.164.20.2253","article-title":"Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer","volume":"164","author":"Glud","year":"2004","journal-title":"Arch Int Med"},{"key":"key\n\t\t\t\t20171012175514_DMM012C21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humupd\/dmi031","article-title":"Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials","volume":"11","author":"Greiser","year":"2005","journal-title":"Human Reprod Update"},{"key":"key\n\t\t\t\t20171012175514_DMM012C22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Third U.S. Preventive Services Task Force. Current methods of the U.S. Preventive Services Task Force. A review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"key\n\t\t\t\t20171012175514_DMM012C23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/oxfordjournals.aje.a114902","article-title":"Menopause and ovarian cancer","volume":"127","author":"Hartge","year":"1988","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2105\/AJPH.78.11.1479","article-title":"Prescribing of noncontraceptive estrogens and progestins in the United States, 1974\u20131986","volume":"78","author":"Hemminki","year":"1988","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20171012175514_DMM012C25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0029-7844(97)00118-X","article-title":"Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study","volume":"89","author":"Hempling","year":"1997","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20171012175514_DMM012C27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171012175514_DMM012C28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/oxfordjournals.aje.a113207","article-title":"An epidemiologic study of epithelial carcinoma of the ovary","volume":"114","author":"Hildreth","year":"1981","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.AOG.0000220502.77153.5a","article-title":"Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001\u20132003","volume":"108","author":"Hing","year":"2006","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1471-0528.1987.tb03166.x","article-title":"Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy","volume":"94","author":"Hunt","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C31","volume-title":"Combined Estrogen\u2013Progestogen Menopausal Therapy (Group 1). 5. Summary of Data Reported and Evaluation.","author":"IARC Working Group","year":"2006"},{"key":"key\n\t\t\t\t20171012175514_DMM012C32","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/oxfordjournals.aje.a115441","article-title":"Noncontraceptive estrogen use and epithelial ovarian cancer","volume":"130","author":"Kaufman","year":"1989","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10552-005-5383-z","article-title":"Dietary risk factors for ovarian cancer: the adventist health study (United States)","volume":"17","author":"Kiani","year":"2006","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t20171012175514_DMM012C35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2005.07.110","article-title":"Hormone replacement therapy and the risk of ovarian cancer on BRCA1 and BRCA2 mutation carriers","volume":"100","author":"Kotsopoulos","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C36","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.bjc.6601715","article-title":"Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian\u2013Swedish Wome\u0144s lifestyle and health cohort study","volume":"90","author":"Kumle","year":"2004","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2004.10.037","article-title":"Histological types of epithelial ovarian cancer: have they different risk factors?","volume":"96","author":"Kurian","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djj375","article-title":"Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP diet and health study cohort","volume":"98","author":"Lacey","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer","volume":"288","author":"Lacey","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C40","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1001\/jama.288.20.2539-JLT1127-1-3","article-title":"Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women","volume":"288","author":"Lacey","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C41","first-page":"1207","article-title":"Noncontraceptive estrogen use and the occurence of ovarian cancer","volume":"69","author":"La Vecchia","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4684-5047-7_17","article-title":"Estrogen therapy and the risk of breast, ovarian, and endometrial cancer","volume-title":"Aging, Reproduction and the Climacteric","author":"Lee","year":"1986"},{"key":"key\n\t\t\t\t20171012175514_DMM012C43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2004.07.012","article-title":"Epithelial ovarian cancer by invasiveness and cell type in the Central Valley of California","volume":"95","author":"Mills","year":"2004","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cdp.2004.11.002","article-title":"Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk","volume":"29","author":"Mills","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"key\n\t\t\t\t20171012175514_DMM012C45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1047-2797(01)00213-7","article-title":"Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness","volume":"11","author":"Modugno","year":"2001","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajog.2004.11.013","article-title":"Menopausal hormones and risk of ovarian cancer","volume":"193","author":"Moorman","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.gme.0000172595.68648.16","article-title":"Recent reversal of trends in hormone therapy use in a European population","volume":"13","author":"Morabia","year":"2006","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20171012175514_DMM012C48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1349-7006.1998.tb00555.x","article-title":"Anthropometric and other risk factors for ovarian cancer: in a case-control study","volume":"89","author":"Mori","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"key\n\t\t\t\t20171012175514_DMM012C49","volume-title":"International Position Paper on Women's Health and Menopause: A Comprehensive Approach.","author":"National Heart, Lung, and Blood Institute","year":"2002"},{"key":"key\n\t\t\t\t20171012175514_DMM012C50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<848::AID-IJC8>3.0.CO;2-E","article-title":"Hormonal therapy for menopausal and ovarian cancer in a collaborative re-analysis of European studies","volume":"80","author":"Negri","year":"1999","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: scientific review","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C52","first-page":"565","article-title":"Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?","volume":"102","author":"Olsson","year":"2003","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ijc.2910570124","article-title":"Estrogen replacement therapy and ovarian cancer risk","volume":"57","author":"Parazzini","year":"1994","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","article-title":"Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy\u2014long-term follow-up of a Swedish cohort","volume":"67","author":"Persson","year":"1996","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C55","first-page":"63","article-title":"Statistical methods in meta-analysis","volume-title":"Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis","author":"Petitti","year":"2000","edition":"2nd edn"},{"key":"key\n\t\t\t\t20171012175514_DMM012C56","first-page":"289","article-title":"Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek study","volume":"70","author":"Petitti","year":"1987","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.fertnstert.2004.03.013","article-title":"Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study","volume":"82","author":"Pike","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20171012175514_DMM012C58","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1038\/sj.onc.1207899","article-title":"Prevention of cancers of the breast, endometrium and ovary","volume":"23","author":"Pike","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20171012175514_DMM012C59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ijc.2910550312","article-title":"Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer","volume":"55","author":"Polychronopoulou","year":"1993","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1008934919159","article-title":"Incidence of cancer among women using long versus monthly cycle hormone replacement therapy, Finland 1994\u20131997","volume":"12","author":"Pukkala","year":"2001","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t20171012175514_DMM012C61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6690731","article-title":"Hormone replacement therapy and risk of epithelial ovarian cancer","volume":"81","author":"Purdie","year":"1999","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C62","volume-title":"SEER Cancer Statistics Review, 1975\u20132003","author":"Ries","year":"2006"},{"key":"key\n\t\t\t\t20171012175514_DMM012C63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","article-title":"Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study","volume":"83","author":"Riman","year":"2001","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/aje\/kwf048","article-title":"Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study","volume":"156","author":"Riman","year":"2002","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/94.7.497","article-title":"Hormone replacement and the risk of invasive epithelial ovarian cancer in Swedish women","volume":"94","author":"Riman","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1996.0315","article-title":"Estrogen replacement therapy and risk of epithelial ovarian cancer","volume":"63","author":"Risch","year":"1996","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C67","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","article-title":"Differences in risk factors for epithelial ovarian cancer by histologic type","volume":"144","author":"Risch","year":"1996","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C69","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement and ovarian cancer mortality in a large prospective study of US women","volume":"285","author":"Rodriguez","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C70","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1097-0215(20011120)95:6<370::AID-IJC1065>3.0.CO;2-T","article-title":"Low-dose oral contraceptives: protective effect on ovarian cancer risk","volume":"95","author":"Royar","year":"2001","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C71","first-page":"3658","article-title":"Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico","volume":"59","author":"Salazar-Martinez","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171012175514_DMM012C72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/gyno.2002.6746","article-title":"Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma","volume":"86","author":"Sit","year":"2002","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/73.2.371","article-title":"Effects of smoking on the development of female reproductive cancers","volume":"73","author":"Smith","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C74","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","article-title":"A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer","volume":"265","author":"Steinberg","year":"1991","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171012175514_DMM012C75","first-page":"191","article-title":"Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer","volume":"49","author":"The WHO Collaborative Study of Neoplasia and Steroid Contraception","year":"1991","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171012175514_DMM012C76","unstructured":"The Womens'\n          Health Initiative Scientific Resources\n          Website. http:\/\/www.whiscience.org\/publication. (16 May 2007, date last accessed)"},{"key":"key\n\t\t\t\t20171012175514_DMM012C77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C78","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-142-10-200505170-00011","article-title":"Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Service Task Force","volume":"142","author":"U.S. Preventive Service Task Force","year":"2005","journal-title":"Ann Int Med"},{"key":"key\n\t\t\t\t20171012175514_DMM012C79","first-page":"95","article-title":"Noncontraceptive estrogen use and the occurrence of ovarian cancer","volume":"68","author":"Weiss","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171012175514_DMM012C80","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"The Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20171012175514_DMM012C81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0029-7844(94)00339-F","article-title":"Use of menopausal estrogens and medroxyprogesterone in the United States, 1982\u20131992","volume":"8","author":"Wysowski","year":"1995","journal-title":"Obstet Gynecol"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/13\/5\/453\/17055263\/dmm012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:55:15Z","timestamp":1507834515000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humupd\/article\/13\/5\/453\/658116\/Menopausal-hormone-therapy-and-risk-of-ovarian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,15]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,6,15]]},"published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmm012","relation":{},"ISSN":["1460-2369","1355-4786"],"issn-type":[{"value":"1460-2369","type":"electronic"},{"value":"1355-4786","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,9]]},"published":{"date-parts":[[2007,6,15]]}}}